Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karoly Horvat-Karajz"'
Autor:
Zsuzsanna Kahan, Daniela Grecea, Martin Smakal, Sergei Tjulandin, Igor Bondarenko, Luca Perjesi, Andras Illes, Karoly Horvat-Karajz, Ildiko Aradi
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is accepted standard for prevention of chemotherapy-induced neutropenia. RGB-02 (Gedeon Richter) is a proposed biosimilar to pegylated G-CSF (Neulasta
Externí odkaz:
https://doaj.org/article/b249d2754cfd438da7b013d32c4d7e50
Publikováno v:
Future Oncology. 15:2083-2092
Pegfilgrastim is widely used for the prevention of chemotherapy-induced neutropenia. The development and use of biosimilar agents help to rationalize healthcare expenditure and improve access to modern therapies to all who need them. This review focu
Autor:
Igor Bondarenko, Zsuzsanna Kahán, Martin Smakal, Karoly Horvat-Karajz, Andras Illes, Daniela Grecea, Sergei Tjulandin, Luca Perjesi, Ildiko Aradi
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is accepted standard for prevention of chemotherapy-induced neutropenia. RGB-02 (Gedeon Richter) is a proposed biosimilar to pegylated G-CSF (Neulasta®, Amgen)
Autor:
Kahan, Zsuzsanna, Grecea, Daniela, Smakal, Martin, Tjulandin, Sergei, Bondarenko, Igor, Perjesi, Luca, Andras Illes, Karoly Horvat-Karajz, Aradi, Ildiko
List of Ethical Committees who approved the study RGB-02-101.(DOCX 12 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6fb09d96310411ec148317b4f845e4